ANNEXON INC - ENROLLMENT OF PHASE 3 ARCHER II TRIAL EXPECTED TO BE COMPLETED IN Q3 2025, WITH TOPLINE DATA EXPECTED IN SECOND HALF OF 2026
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.